DBT
UTHR icon

Dubuque Bank & Trust’s United Therapeutics UTHR Stock Holding History

Dubuque Bank & Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-447
Closed -$70K – 708
2015
Q4 		$70K Hold
447
– – 0.01% 270
2015
Q3 		$59K Hold
447
– – 0.01% 266
2015
Q2 		$78K Hold
447
– – 0.01% 263
2015
Q1 		$77K Hold
447
– – 0.01% 238
2014
Q4 		$58K Hold
447
– – 0.01% 266
2014
Q3 		$58K Hold
447
– – 0.01% 267
2014
Q2 		$40K Buy
+447
New +$43K 0.01% 353

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dubuque Bank & Trust's UTHR Position: Q1 2016 in Review

Dubuque Bank & Trust sold out of United Therapeutics (UTHR) in Q1 2016, closing a stake of 447 shares — an estimated $70K sold.

Dubuque Bank & Trust first reported a position in UTHR in Q2 2014 and held it in 7 quarters. The position peaked at $78K in Q2 2015. 398 funds tracked by Wall St. Rank hold UTHR as of Q1 2016.

  • Dubuque Bank & Trust reported no remaining United Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Dubuque Bank & Trust sold 447 United Therapeutics shares in Q1 2016, an estimated $70K.
  • Dubuque Bank & Trust first reported a position in United Therapeutics in Q2 2014 and held it in 7 quarters.
  • Dubuque Bank & Trust's United Therapeutics position peaked at $78K in Q2 2015.
  • 398 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2016.

Based on Dubuque Bank & Trust's 13F filing for Q1 2016, filed 5 May 2016.